Outcomes of surgical resection and intraoperative electron radiotherapy for patients with para-aortic recurrences of gastrointestinal and gynecologic malignancies
- PMID: 37268927
- PMCID: PMC10239077
- DOI: 10.1186/s13014-023-02289-2
Outcomes of surgical resection and intraoperative electron radiotherapy for patients with para-aortic recurrences of gastrointestinal and gynecologic malignancies
Abstract
Background: Para-aortic lymph node (PALN) metastases from primary pelvic malignancies are often treated with resection, but recurrence is common. We report toxicity and oncologic outcomes for patients with PALN metastases from gastrointestinal and gynecologic malignancies treated with resection and intraoperative electron radiotherapy (IORT).
Methods: We retrospectively identified patients with recurrent PALN metastases who underwent resection with IORT. All patients were included in the local recurrence (LR) and toxicity analyses. Only patients with primary colorectal tumors were included in the survival analysis.
Results: There were 26 patients with a median follow up of 10.4 months. The rate of para-aortic local control (LC) was 77% (20/26 patients) and the rate of any cancer recurrence was 58% (15/26 patients). Median time from surgery and IORT to any recurrence was 7 months. The LR rate for those with positive/close margins was 58% (7/12 patients) versus 7% (1/14 patients) for those with negative margins (p = 0.009). 15% (4/26 patients) developed surgical wound and/or infectious complications, 8% (2/26 patients) developed lower extremity edema, 8% (2/26 patients) experienced diarrhea, and 19% (5/26 patients) developed an acute kidney injury. There were no reported nerve injuries, bowel perforations, or bowel obstructions. For patients with primary colorectal tumors (n = 19), the median survival (OS) was 23 months.
Conclusions: We report favorable LC and acceptable toxicity for patients receiving surgical resection and IORT for a population that has historically poor outcomes. Our data show disease control rates similar to literature comparisons for patients with strong risk factors for LR, such as positive/close margins.
Keywords: Colorectal metastases; Intraoperative radiotherapy; Para-aortic recurrence.
© 2023. The Author(s).
Conflict of interest statement
Certain authors (denoted on the Title page) are employed by the University of North Carolina. There are otherwise no conflicts of interest to disclose.
Certain authors (listed above) are employed by the University of North Carolina. There are otherwise no conflicts of interest to disclose.
Figures
Similar articles
-
Intraoperative radiation therapy for the treatment of recurrent retroperitoneal and pelvic tumors: a single-institution analysis.Radiat Oncol. 2018 Nov 20;13(1):224. doi: 10.1186/s13014-018-1168-x. Radiat Oncol. 2018. PMID: 30454036 Free PMC article. Clinical Trial.
-
Long-Term Survival After High-Dose-Rate Brachytherapy for Locally Advanced or Recurrent Colorectal Adenocarcinoma.Ann Surg Oncol. 2015 Jul;22(7):2168-78. doi: 10.1245/s10434-014-4271-8. Epub 2015 Jan 29. Ann Surg Oncol. 2015. PMID: 25631062 Free PMC article.
-
Intraoperative pelvic brachytherapy for treatment of locally advanced or recurrent colorectal cancer.Tech Coloproctol. 2013 Feb;17(1):95-100. doi: 10.1007/s10151-012-0892-8. Epub 2012 Sep 18. Tech Coloproctol. 2013. PMID: 22986843 Free PMC article.
-
Intraoperative radiation therapy in the management of gynecologic and genitourinary malignancies.Surg Oncol Clin N Am. 2003 Oct;12(4):1031-42. doi: 10.1016/s1055-3207(03)00086-3. Surg Oncol Clin N Am. 2003. PMID: 14989131 Review.
-
Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix.Int J Radiat Oncol Biol Phys. 2003 Apr 1;55(5):1247-53. doi: 10.1016/s0360-3016(02)04401-2. Int J Radiat Oncol Biol Phys. 2003. PMID: 12654434 Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical